Abstract
We report a patient with multifocal motor neuropathy (MMN) who experienced a paradoxical decline in baseline strength to below pretreatment levels during a period of improvement associated with human immunoglobulin (HIG) administration. This outcome suggests that HIG may not limit progression of MMN and may reduce the utility of HIG as chronic therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 967-968 |
| Number of pages | 2 |
| Journal | Neurology |
| Volume | 44 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 1994 |